ArticleTherapeutic advances in endocrinology and metabolism2013

Safety and efficacy of linagliptin in type 2 diabetes patients with common renal and cardiovascular risk factors.

Baptist GallwitzPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.